Make Naloxone a Routine Part of Opioid Discharge Education
November 2021
New naloxone (Kloxxado) 8 mg nasal spray will raise questions about which dose to provide patients taking opioids.
We're used to ensuring patients get a discharge Rx for naloxone 4 mg intranasal or 0.4 mg IM.
Kloxxado is touted as having "twice as much naloxone per spray" as Narcan nasal spray. And people are hearing that higher doses may be needed, since overdoses from "ultra-potent" fentanyl-like compounds are rising.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote